NJ State Employees Deferred Compensation Plan reduced its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report) by 29.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 19,000 shares of the financial services provider’s stock after selling 8,000 […]
NJ State Employees Deferred Compensation Plan bought a new stake in shares of CenterPoint Energy, Inc. (NYSE:CNP – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 27,000 shares of the utilities provider’s stock, valued at approximately $795,000. […]
NJ State Employees Deferred Compensation Plan purchased a new stake in CMS Energy Co. (NYSE:CMS – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 22,000 shares of the utilities provider’s stock, valued at approximately $1,350,000. Several other institutional investors […]
NJ State Employees Deferred Compensation Plan boosted its stake in shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX – Free Report) by 275.0% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 15,000 shares of the biopharmaceutical company’s stock after purchasing an additional 11,000 shares during the period. NJ State […]
NJ State Employees Deferred Compensation Plan raised its position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) by 77.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,500 shares of the company’s stock after acquiring an additional 2,400 shares […]